Pulmonary Arterial Hypertension and Pulmonary Hypertension associated with Interstitial Lung Disease
Conditions
Interventions
The initial dose of treprostinil should be set at one 16 mcg per treatment session, 4 times a day.
If tolerated, the dose can be gradually increased up to 64 mcg and maintained.
Sponsors
Takahashi Kenta
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient was diagnosed as either idiopathic or heritable PAH, drug- and toxin-induced PAH,CTD-PAH, HIV-PAH, CHD-PAH or PH associated with ILD or CPFE
Exclusion criteria
Exclusion criteria: Patient was diagnosed as PH other than those accepted as outlined in the Inclusion Criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of change in pulmonary vascular resistance index | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of change in 6-minute walk distance, etc | — |
Contacts
Public ContactPublic relations
Mochida Pharmaceutical Co., Ltd.
Outcome results
None listed